SNCE News and Press, Science 37 Holdings Inc. From 11/22/22

RESEARCH TRIANGLE PARK, N.C. and STAMFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, and BEKHealth, a leading clinical research platform, today announced a partnership that will enable Science 37 to access the E...

RESEARCH TRIANGLE PARK, N.C. and OSAKA, Japan, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, and Linical Americas, a U.S. subsidiary of The Linical Group, a leading global contract research organization (CRO), today announced a pa...

RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, was named as winner in the Telehealth Innovation category at the University of California San Francisco (UCSF) Health Hub Digital Health Awards, a...

Start Time: 08:30 End Time: 09:07 Science 37 Holdings, Inc. (SNCE) Q3 2022 Earnings Conference Call November 11, 2022, 08:30 AM ET Company Participants David Coman - CEO Mike Zaranek - CFO Steve Halper - Managing Director, LifeSci Advisors Conferenc...

Science 37 press release ( NASDAQ: SNCE ): Q3 GAAP EPS of -$0.20 misses by $0.02 . Revenue of $16.25M (+14.1% Y/Y) misses by $3.61M . For further details see: Science 37 GAAP EPS of -$0.20 misses by $0.02, revenue of $16.25M misses by $3.61M

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial results for the quarter ended September 30, 2022. “The third...

RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022 financial results after the market closes on Thursday, November 10, 2022. Company man...

RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Science 37 ® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the appointment of seasoned industry and technology executive Paul von Autenried to its Board of Directors....

RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced that Michael Shipton has been appointed Chief Commercial Officer to lead business development, strategic solutions, s...

RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37 ® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Baird Global Healthcare Conference in New York. Sc...